Patents by Inventor Daniel Charles Stewart

Daniel Charles Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bortezomib compositions
    Patent number: 12005069
    Abstract: The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
    Type: Grant
    Filed: August 28, 2023
    Date of Patent: June 11, 2024
    Assignee: MAIA PHARMACEUTICALS, INC.
    Inventors: Srikanth Sundaram, Daniel Charles Stewart
  • BORTEZOMIB COMPOSITIONS
    Publication number: 20230405029
    Abstract: The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
    Type: Application
    Filed: August 28, 2023
    Publication date: December 21, 2023
    Inventors: Srikanth SUNDARAM, Daniel Charles STEWART
  • Bortezomib compositions
    Patent number: 11752164
    Abstract: The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
    Type: Grant
    Filed: March 22, 2023
    Date of Patent: September 12, 2023
    Assignee: MAIA PHARMACEUTICALS, INC.
    Inventors: Srikanth Sundaram, Daniel Charles Stewart
  • BORTEZOMIB COMPOSITIONS
    Publication number: 20230218647
    Abstract: The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
    Type: Application
    Filed: March 22, 2023
    Publication date: July 13, 2023
    Inventors: Srikanth SUNDARAM, Daniel Charles STEWART
  • Bortezomib compositions
    Patent number: 11679119
    Abstract: The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
    Type: Grant
    Filed: September 23, 2022
    Date of Patent: June 20, 2023
    Assignee: MAIA PHARMACEUTICALS, INC.
    Inventors: Srikanth Sundaram, Daniel Charles Stewart
  • Bortezomib compositions
    Patent number: 11672813
    Abstract: The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
    Type: Grant
    Filed: September 23, 2022
    Date of Patent: June 13, 2023
    Assignee: MAIA PHARMACEUTICALS, INC.
    Inventors: Srikanth Sundaram, Daniel Charles Stewart
  • BORTEZOMIB COMPOSITIONS
    Publication number: 20230104074
    Abstract: The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
    Type: Application
    Filed: September 23, 2022
    Publication date: April 6, 2023
    Inventors: Srikanth Sundaram, Daniel Charles Stewart
  • BORTEZOMIB COMPOSITIONS
    Publication number: 20230102141
    Abstract: The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
    Type: Application
    Filed: September 23, 2022
    Publication date: March 30, 2023
    Inventors: Srikanth Sundaram, Daniel Charles Stewart
  • BORTEZOMIB COMPOSITIONS
    Publication number: 20230097975
    Abstract: The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
    Type: Application
    Filed: September 23, 2022
    Publication date: March 30, 2023
    Inventors: Srikanth Sundaram, Daniel Charles Stewart
  • BORTEZOMIB COMPOSITIONS
    Publication number: 20230096601
    Abstract: The present disclosure relates to ready-to-use liquid aqueous ortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
    Type: Application
    Filed: September 23, 2022
    Publication date: March 30, 2023
    Inventors: Srikanth Sundaram, Daniel Charles Stewart
  • Needle Shield
    Publication number: 20150217061
    Abstract: A needle shield comprises an elastomeric sheath having a closed distal end and an open proximal end. The distal end is configured to form a first seal with a distal tip of a needle in an initial position. The proximal end is configured to form a second seal with a syringe body in the initial position. The second seal is configured to release from the syringe body prior to the first seal releasing from the needle when the elastomeric sheath is moved distally from the syringe.
    Type: Application
    Filed: August 20, 2013
    Publication date: August 6, 2015
    Applicant: ANTARES PHARMA, INC.
    Inventors: Peter L. Sadowski, Michael Travanty, Kaushik J. Dave, Daniel Charles Stewart, Patrick Madsen, Julius Sund
  • Taste masking of oral quinolone liquid preparations using ion exchange resins
    Patent number: 6514492
    Abstract: This invention relates to the formulation of oral liquid products of quinolones or derivatives thereof using ion exchange resins, such as methacrylic acid polymer crosslinked with divinylbenzene, as the carrier, thereby eliminating the extreme bitterness of the quinolones oral liquid formulation.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: February 4, 2003
    Assignee: Schering-Plough Veterinary Corporation
    Inventors: Rong Gao, Zezhi Jesse Shao, Allan Chor-Lun Fan, Leonore Catherine Witchey-Lakshmanan, Daniel Charles Stewart